Mount Sinai Developing an “End-to-End” Diagnostics Solution for COVID-19 That Incorporates Diagnosis, Treatment Selection, and Monitoring of Disease Course

An expert team of researchers and clinicians have been working together to design, validate, and implement an “end-to-end” clinical pathology laboratory solution that will allow for the testing of approximately several hundred people per day in order to rapidly diagnose and help guide the selection of treatment and monitor disease course.

Read more

Mount Sinai Health System Appoints Niyum Gandhi as New Chief Financial Officer

Mr. Gandhi, who has served as Executive Vice President and Chief Population Health Officer at Mount Sinai since 2015, succeeds Donald Scanlon, who will step down from his position later this year and will assist with the transition.

Read more

Rachel Vreeman Appointed Chair of Global Health and Director of the Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai

Appointment Enhances Efforts by the Institute to Improve Health of Communities Locally and Internationally

Read more

Mount Sinai and Harbour BioMed Collaborate to Advance Novel Biotherapies for the Treatment of Cancer and Coronavirus COVID-19

Collaboration combines Harbour BioMed’s proprietary H2L2 Harbour Mice® platform for fully human monoclonal antibody generation with Mount Sinai’s translational medical research expertise.

Read more

Artificial Intelligence Can Scan Doctors’ Notes to Distinguish Between Types of Back Pain

Mount Sinai researchers have designed an artificial intelligence model that can determine whether lower back pain is acute or chronic by scouring doctors’ notes within electronic medical records, an approach that can help to treat patients more accurately, according to a study published in the Journal of Medical Internet Research in February.

Read more